nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Fingolimod—multiple sclerosis	0.145	0.246	CbGbCtD
Sufentanil—CYP3A4—Methylprednisolone—multiple sclerosis	0.0932	0.158	CbGbCtD
Sufentanil—CYP3A4—Triamcinolone—multiple sclerosis	0.0707	0.12	CbGbCtD
Sufentanil—CYP3A4—Mitoxantrone—multiple sclerosis	0.068	0.116	CbGbCtD
Sufentanil—CYP3A4—Betamethasone—multiple sclerosis	0.0606	0.103	CbGbCtD
Sufentanil—CYP3A4—Prednisolone—multiple sclerosis	0.0598	0.102	CbGbCtD
Sufentanil—CYP3A4—Prednisone—multiple sclerosis	0.0565	0.0959	CbGbCtD
Sufentanil—CYP3A4—Dexamethasone—multiple sclerosis	0.0353	0.0599	CbGbCtD
Sufentanil—Cardiac arrest—Fingolimod—multiple sclerosis	0.00639	0.032	CcSEcCtD
Sufentanil—Bradycardia—Fingolimod—multiple sclerosis	0.00473	0.0237	CcSEcCtD
Sufentanil—Hypertension—Fingolimod—multiple sclerosis	0.00349	0.0175	CcSEcCtD
Sufentanil—Hypotension—Fingolimod—multiple sclerosis	0.00309	0.0155	CcSEcCtD
Sufentanil—Urinary tract disorder—Cladribine—multiple sclerosis	0.0026	0.013	CcSEcCtD
Sufentanil—Urethral disorder—Cladribine—multiple sclerosis	0.00258	0.0129	CcSEcCtD
Sufentanil—Euphoric mood—Prednisolone—multiple sclerosis	0.00243	0.0122	CcSEcCtD
Sufentanil—Chills—Cladribine—multiple sclerosis	0.00236	0.0118	CcSEcCtD
Sufentanil—Arrhythmia—Cladribine—multiple sclerosis	0.00235	0.0118	CcSEcCtD
Sufentanil—Pruritus—Fingolimod—multiple sclerosis	0.00234	0.0117	CcSEcCtD
Sufentanil—Erythema—Cladribine—multiple sclerosis	0.00229	0.0115	CcSEcCtD
Sufentanil—Euphoric mood—Triamcinolone—multiple sclerosis	0.00224	0.0112	CcSEcCtD
Sufentanil—Euphoric mood—Methylprednisolone—multiple sclerosis	0.00223	0.0112	CcSEcCtD
Sufentanil—Dizziness—Fingolimod—multiple sclerosis	0.00218	0.0109	CcSEcCtD
Sufentanil—Headache—Fingolimod—multiple sclerosis	0.00207	0.0104	CcSEcCtD
Sufentanil—Euphoric mood—Dexamethasone—multiple sclerosis	0.00203	0.0102	CcSEcCtD
Sufentanil—Euphoric mood—Betamethasone—multiple sclerosis	0.00203	0.0102	CcSEcCtD
Sufentanil—Apnoea—Methotrexate—multiple sclerosis	0.00203	0.0101	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisolone—multiple sclerosis	0.00195	0.00978	CcSEcCtD
Sufentanil—Chills—Azathioprine—multiple sclerosis	0.00192	0.00963	CcSEcCtD
Sufentanil—Arrhythmia—Azathioprine—multiple sclerosis	0.00191	0.00958	CcSEcCtD
Sufentanil—Confusional state—Cladribine—multiple sclerosis	0.00189	0.00945	CcSEcCtD
Sufentanil—Tachycardia—Cladribine—multiple sclerosis	0.00183	0.00915	CcSEcCtD
Sufentanil—Cardiac arrest—Triamcinolone—multiple sclerosis	0.0018	0.00899	CcSEcCtD
Sufentanil—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00179	0.00897	CcSEcCtD
Sufentanil—Euphoric mood—Prednisone—multiple sclerosis	0.00177	0.00885	CcSEcCtD
Sufentanil—Bradycardia—Mitoxantrone—multiple sclerosis	0.00176	0.00883	CcSEcCtD
Sufentanil—Hypotension—Cladribine—multiple sclerosis	0.00175	0.00876	CcSEcCtD
Sufentanil—OPRM1—nerve—multiple sclerosis	0.00173	0.207	CbGeAlD
Sufentanil—Somnolence—Cladribine—multiple sclerosis	0.00166	0.00833	CcSEcCtD
Sufentanil—Cardiac arrest—Betamethasone—multiple sclerosis	0.00163	0.00816	CcSEcCtD
Sufentanil—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00163	0.00816	CcSEcCtD
Sufentanil—Bronchospasm—Methylprednisolone—multiple sclerosis	0.0016	0.00802	CcSEcCtD
Sufentanil—Chills—Mitoxantrone—multiple sclerosis	0.00155	0.00778	CcSEcCtD
Sufentanil—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00155	0.00775	CcSEcCtD
Sufentanil—Feeling abnormal—Cladribine—multiple sclerosis	0.00154	0.00772	CcSEcCtD
Sufentanil—Erythema—Mitoxantrone—multiple sclerosis	0.00151	0.00755	CcSEcCtD
Sufentanil—Body temperature increased—Cladribine—multiple sclerosis	0.00148	0.00741	CcSEcCtD
Sufentanil—Bradycardia—Prednisolone—multiple sclerosis	0.00145	0.00724	CcSEcCtD
Sufentanil—Hypotension—Azathioprine—multiple sclerosis	0.00142	0.00712	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisone—multiple sclerosis	0.00142	0.00711	CcSEcCtD
Sufentanil—Hypersensitivity—Cladribine—multiple sclerosis	0.00138	0.00691	CcSEcCtD
Sufentanil—Bradycardia—Triamcinolone—multiple sclerosis	0.00133	0.00666	CcSEcCtD
Sufentanil—Bradycardia—Methylprednisolone—multiple sclerosis	0.00133	0.00665	CcSEcCtD
Sufentanil—Pruritus—Cladribine—multiple sclerosis	0.00132	0.00663	CcSEcCtD
Sufentanil—Hypertension—Mitoxantrone—multiple sclerosis	0.0013	0.00652	CcSEcCtD
Sufentanil—Arrhythmia—Prednisolone—multiple sclerosis	0.00127	0.00636	CcSEcCtD
Sufentanil—Feeling abnormal—Azathioprine—multiple sclerosis	0.00125	0.00628	CcSEcCtD
Sufentanil—Confusional state—Mitoxantrone—multiple sclerosis	0.00124	0.00621	CcSEcCtD
Sufentanil—Dizziness—Cladribine—multiple sclerosis	0.00124	0.0062	CcSEcCtD
Sufentanil—Erythema—Prednisolone—multiple sclerosis	0.00124	0.00619	CcSEcCtD
Sufentanil—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00123	0.00616	CcSEcCtD
Sufentanil—Bradycardia—Dexamethasone—multiple sclerosis	0.00121	0.00604	CcSEcCtD
Sufentanil—Bradycardia—Betamethasone—multiple sclerosis	0.00121	0.00604	CcSEcCtD
Sufentanil—Body temperature increased—Azathioprine—multiple sclerosis	0.0012	0.00602	CcSEcCtD
Sufentanil—Tachycardia—Mitoxantrone—multiple sclerosis	0.0012	0.00601	CcSEcCtD
Sufentanil—Vomiting—Cladribine—multiple sclerosis	0.00119	0.00596	CcSEcCtD
Sufentanil—Rash—Cladribine—multiple sclerosis	0.00118	0.00591	CcSEcCtD
Sufentanil—Dermatitis—Cladribine—multiple sclerosis	0.00118	0.0059	CcSEcCtD
Sufentanil—Headache—Cladribine—multiple sclerosis	0.00117	0.00587	CcSEcCtD
Sufentanil—Arrhythmia—Triamcinolone—multiple sclerosis	0.00117	0.00584	CcSEcCtD
Sufentanil—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00116	0.00583	CcSEcCtD
Sufentanil—Hypotension—Mitoxantrone—multiple sclerosis	0.00115	0.00576	CcSEcCtD
Sufentanil—Erythema—Triamcinolone—multiple sclerosis	0.00114	0.0057	CcSEcCtD
Sufentanil—Erythema—Methylprednisolone—multiple sclerosis	0.00113	0.00568	CcSEcCtD
Sufentanil—Hypersensitivity—Azathioprine—multiple sclerosis	0.00112	0.00562	CcSEcCtD
Sufentanil—Nausea—Cladribine—multiple sclerosis	0.00111	0.00557	CcSEcCtD
Sufentanil—Somnolence—Mitoxantrone—multiple sclerosis	0.00109	0.00548	CcSEcCtD
Sufentanil—Hypertension—Prednisolone—multiple sclerosis	0.00107	0.00535	CcSEcCtD
Sufentanil—Arrhythmia—Dexamethasone—multiple sclerosis	0.00106	0.0053	CcSEcCtD
Sufentanil—Arrhythmia—Betamethasone—multiple sclerosis	0.00106	0.0053	CcSEcCtD
Sufentanil—Bradycardia—Prednisone—multiple sclerosis	0.00105	0.00526	CcSEcCtD
Sufentanil—Erythema—Dexamethasone—multiple sclerosis	0.00103	0.00517	CcSEcCtD
Sufentanil—Erythema—Betamethasone—multiple sclerosis	0.00103	0.00517	CcSEcCtD
Sufentanil—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00101	0.00508	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00101	0.00505	CcSEcCtD
Sufentanil—Dizziness—Azathioprine—multiple sclerosis	0.00101	0.00504	CcSEcCtD
Sufentanil—Tachycardia—Prednisolone—multiple sclerosis	0.000985	0.00493	CcSEcCtD
Sufentanil—Hypertension—Triamcinolone—multiple sclerosis	0.000982	0.00492	CcSEcCtD
Sufentanil—Hypertension—Methylprednisolone—multiple sclerosis	0.00098	0.00491	CcSEcCtD
Sufentanil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000972	0.00487	CcSEcCtD
Sufentanil—Vomiting—Azathioprine—multiple sclerosis	0.000968	0.00485	CcSEcCtD
Sufentanil—Rash—Azathioprine—multiple sclerosis	0.000959	0.00481	CcSEcCtD
Sufentanil—Dermatitis—Azathioprine—multiple sclerosis	0.000959	0.0048	CcSEcCtD
Sufentanil—Headache—Azathioprine—multiple sclerosis	0.000953	0.00477	CcSEcCtD
Sufentanil—Confusional state—Methylprednisolone—multiple sclerosis	0.000934	0.00468	CcSEcCtD
Sufentanil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000928	0.00465	CcSEcCtD
Sufentanil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000926	0.00464	CcSEcCtD
Sufentanil—Arrhythmia—Prednisone—multiple sclerosis	0.000922	0.00462	CcSEcCtD
Sufentanil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000906	0.00454	CcSEcCtD
Sufentanil—Tachycardia—Triamcinolone—multiple sclerosis	0.000906	0.00454	CcSEcCtD
Sufentanil—Nausea—Azathioprine—multiple sclerosis	0.000904	0.00453	CcSEcCtD
Sufentanil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000904	0.00453	CcSEcCtD
Sufentanil—Erythema—Prednisone—multiple sclerosis	0.000899	0.0045	CcSEcCtD
Sufentanil—Hypertension—Dexamethasone—multiple sclerosis	0.000891	0.00446	CcSEcCtD
Sufentanil—Hypertension—Betamethasone—multiple sclerosis	0.000891	0.00446	CcSEcCtD
Sufentanil—Hypotension—Methylprednisolone—multiple sclerosis	0.000865	0.00433	CcSEcCtD
Sufentanil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000852	0.00427	CcSEcCtD
Sufentanil—Urethral disorder—Methotrexate—multiple sclerosis	0.000846	0.00424	CcSEcCtD
Sufentanil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000842	0.00422	CcSEcCtD
Sufentanil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000842	0.00422	CcSEcCtD
Sufentanil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000832	0.00417	CcSEcCtD
Sufentanil—Tachycardia—Betamethasone—multiple sclerosis	0.000822	0.00412	CcSEcCtD
Sufentanil—Tachycardia—Dexamethasone—multiple sclerosis	0.000822	0.00412	CcSEcCtD
Sufentanil—Hypotension—Dexamethasone—multiple sclerosis	0.000787	0.00394	CcSEcCtD
Sufentanil—Hypotension—Betamethasone—multiple sclerosis	0.000787	0.00394	CcSEcCtD
Sufentanil—Vomiting—Mitoxantrone—multiple sclerosis	0.000782	0.00392	CcSEcCtD
Sufentanil—Hypertension—Prednisone—multiple sclerosis	0.000776	0.00389	CcSEcCtD
Sufentanil—Rash—Mitoxantrone—multiple sclerosis	0.000776	0.00388	CcSEcCtD
Sufentanil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000775	0.00388	CcSEcCtD
Sufentanil—Chills—Methotrexate—multiple sclerosis	0.000774	0.00388	CcSEcCtD
Sufentanil—Headache—Mitoxantrone—multiple sclerosis	0.000771	0.00386	CcSEcCtD
Sufentanil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000765	0.00383	CcSEcCtD
Sufentanil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000763	0.00382	CcSEcCtD
Sufentanil—Erythema—Methotrexate—multiple sclerosis	0.000751	0.00376	CcSEcCtD
Sufentanil—OPRM1—brainstem—multiple sclerosis	0.000745	0.089	CbGeAlD
Sufentanil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000744	0.00372	CcSEcCtD
Sufentanil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000734	0.00367	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000733	0.00367	CcSEcCtD
Sufentanil—Nausea—Mitoxantrone—multiple sclerosis	0.000731	0.00366	CcSEcCtD
Sufentanil—Tachycardia—Prednisone—multiple sclerosis	0.000716	0.00358	CcSEcCtD
Sufentanil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000694	0.00348	CcSEcCtD
Sufentanil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000694	0.00348	CcSEcCtD
Sufentanil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000684	0.00342	CcSEcCtD
Sufentanil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000682	0.00342	CcSEcCtD
Sufentanil—Dizziness—Prednisolone—multiple sclerosis	0.000667	0.00334	CcSEcCtD
Sufentanil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000666	0.00333	CcSEcCtD
Sufentanil—Body temperature increased—Betamethasone—multiple sclerosis	0.000666	0.00333	CcSEcCtD
Sufentanil—Pruritus—Triamcinolone—multiple sclerosis	0.000657	0.00329	CcSEcCtD
Sufentanil—Pruritus—Methylprednisolone—multiple sclerosis	0.000655	0.00328	CcSEcCtD
Sufentanil—Rash—Prednisolone—multiple sclerosis	0.000636	0.00319	CcSEcCtD
Sufentanil—Dermatitis—Prednisolone—multiple sclerosis	0.000636	0.00318	CcSEcCtD
Sufentanil—Headache—Prednisolone—multiple sclerosis	0.000632	0.00317	CcSEcCtD
Sufentanil—Confusional state—Methotrexate—multiple sclerosis	0.000618	0.0031	CcSEcCtD
Sufentanil—Dizziness—Triamcinolone—multiple sclerosis	0.000614	0.00307	CcSEcCtD
Sufentanil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000613	0.00307	CcSEcCtD
Sufentanil—Dizziness—Methylprednisolone—multiple sclerosis	0.000612	0.00307	CcSEcCtD
Sufentanil—Feeling abnormal—Prednisone—multiple sclerosis	0.000604	0.00303	CcSEcCtD
Sufentanil—Nausea—Prednisolone—multiple sclerosis	0.000599	0.003	CcSEcCtD
Sufentanil—Pruritus—Dexamethasone—multiple sclerosis	0.000596	0.00298	CcSEcCtD
Sufentanil—Pruritus—Betamethasone—multiple sclerosis	0.000596	0.00298	CcSEcCtD
Sufentanil—Vomiting—Triamcinolone—multiple sclerosis	0.00059	0.00296	CcSEcCtD
Sufentanil—Vomiting—Methylprednisolone—multiple sclerosis	0.000589	0.00295	CcSEcCtD
Sufentanil—Rash—Triamcinolone—multiple sclerosis	0.000585	0.00293	CcSEcCtD
Sufentanil—Dermatitis—Triamcinolone—multiple sclerosis	0.000585	0.00293	CcSEcCtD
Sufentanil—Rash—Methylprednisolone—multiple sclerosis	0.000584	0.00292	CcSEcCtD
Sufentanil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000583	0.00292	CcSEcCtD
Sufentanil—Headache—Triamcinolone—multiple sclerosis	0.000581	0.00291	CcSEcCtD
Sufentanil—Headache—Methylprednisolone—multiple sclerosis	0.00058	0.00291	CcSEcCtD
Sufentanil—Body temperature increased—Prednisone—multiple sclerosis	0.00058	0.0029	CcSEcCtD
Sufentanil—Hypotension—Methotrexate—multiple sclerosis	0.000573	0.00287	CcSEcCtD
Sufentanil—OPRD1—nervous system—multiple sclerosis	0.000572	0.0684	CbGeAlD
Sufentanil—Dizziness—Betamethasone—multiple sclerosis	0.000557	0.00279	CcSEcCtD
Sufentanil—Dizziness—Dexamethasone—multiple sclerosis	0.000557	0.00279	CcSEcCtD
Sufentanil—Nausea—Triamcinolone—multiple sclerosis	0.000551	0.00276	CcSEcCtD
Sufentanil—OPRD1—central nervous system—multiple sclerosis	0.000551	0.0658	CbGeAlD
Sufentanil—Nausea—Methylprednisolone—multiple sclerosis	0.00055	0.00275	CcSEcCtD
Sufentanil—OPRK1—nervous system—multiple sclerosis	0.000548	0.0655	CbGeAlD
Sufentanil—Somnolence—Methotrexate—multiple sclerosis	0.000545	0.00273	CcSEcCtD
Sufentanil—Hypersensitivity—Prednisone—multiple sclerosis	0.00054	0.00271	CcSEcCtD
Sufentanil—Vomiting—Dexamethasone—multiple sclerosis	0.000535	0.00268	CcSEcCtD
Sufentanil—Vomiting—Betamethasone—multiple sclerosis	0.000535	0.00268	CcSEcCtD
Sufentanil—Rash—Dexamethasone—multiple sclerosis	0.000531	0.00266	CcSEcCtD
Sufentanil—Rash—Betamethasone—multiple sclerosis	0.000531	0.00266	CcSEcCtD
Sufentanil—Dermatitis—Betamethasone—multiple sclerosis	0.00053	0.00266	CcSEcCtD
Sufentanil—Dermatitis—Dexamethasone—multiple sclerosis	0.00053	0.00266	CcSEcCtD
Sufentanil—OPRK1—central nervous system—multiple sclerosis	0.000528	0.0631	CbGeAlD
Sufentanil—Headache—Dexamethasone—multiple sclerosis	0.000528	0.00264	CcSEcCtD
Sufentanil—Headache—Betamethasone—multiple sclerosis	0.000528	0.00264	CcSEcCtD
Sufentanil—Pruritus—Prednisone—multiple sclerosis	0.000519	0.0026	CcSEcCtD
Sufentanil—OPRK1—cerebellum—multiple sclerosis	0.000516	0.0617	CbGeAlD
Sufentanil—Feeling abnormal—Methotrexate—multiple sclerosis	0.000505	0.00253	CcSEcCtD
Sufentanil—Nausea—Dexamethasone—multiple sclerosis	0.0005	0.00251	CcSEcCtD
Sufentanil—Nausea—Betamethasone—multiple sclerosis	0.0005	0.00251	CcSEcCtD
Sufentanil—Dizziness—Prednisone—multiple sclerosis	0.000485	0.00243	CcSEcCtD
Sufentanil—Body temperature increased—Methotrexate—multiple sclerosis	0.000485	0.00243	CcSEcCtD
Sufentanil—OPRM1—midbrain—multiple sclerosis	0.000475	0.0567	CbGeAlD
Sufentanil—Vomiting—Prednisone—multiple sclerosis	0.000466	0.00234	CcSEcCtD
Sufentanil—OPRM1—spinal cord—multiple sclerosis	0.000463	0.0553	CbGeAlD
Sufentanil—Rash—Prednisone—multiple sclerosis	0.000462	0.00232	CcSEcCtD
Sufentanil—Dermatitis—Prednisone—multiple sclerosis	0.000462	0.00231	CcSEcCtD
Sufentanil—Headache—Prednisone—multiple sclerosis	0.000459	0.0023	CcSEcCtD
Sufentanil—Hypersensitivity—Methotrexate—multiple sclerosis	0.000452	0.00226	CcSEcCtD
Sufentanil—OPRD1—brain—multiple sclerosis	0.000437	0.0523	CbGeAlD
Sufentanil—Nausea—Prednisone—multiple sclerosis	0.000436	0.00218	CcSEcCtD
Sufentanil—Pruritus—Methotrexate—multiple sclerosis	0.000434	0.00217	CcSEcCtD
Sufentanil—OPRK1—brain—multiple sclerosis	0.000419	0.0501	CbGeAlD
Sufentanil—Dizziness—Methotrexate—multiple sclerosis	0.000405	0.00203	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000402	0.00198	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000393	0.00193	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000393	0.00193	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.000391	0.00192	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00039	0.00192	CbGpPWpGaD
Sufentanil—OPRM1—nervous system—multiple sclerosis	0.00039	0.0466	CbGeAlD
Sufentanil—Vomiting—Methotrexate—multiple sclerosis	0.00039	0.00195	CcSEcCtD
Sufentanil—Rash—Methotrexate—multiple sclerosis	0.000386	0.00194	CcSEcCtD
Sufentanil—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000386	0.0019	CbGpPWpGaD
Sufentanil—Dermatitis—Methotrexate—multiple sclerosis	0.000386	0.00193	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000386	0.0019	CbGpPWpGaD
Sufentanil—Headache—Methotrexate—multiple sclerosis	0.000384	0.00192	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000382	0.00188	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.000381	0.00187	CbGpPWpGaD
Sufentanil—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.00038	0.00187	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CNR1—multiple sclerosis	0.000376	0.00185	CbGpPWpGaD
Sufentanil—OPRM1—central nervous system—multiple sclerosis	0.000376	0.0449	CbGeAlD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000376	0.00185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.000374	0.00184	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000372	0.00183	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.00037	0.00182	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00037	0.00182	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000366	0.0018	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000366	0.0018	CbGpPWpGaD
Sufentanil—Nausea—Methotrexate—multiple sclerosis	0.000364	0.00182	CcSEcCtD
Sufentanil—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000357	0.00176	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000357	0.00176	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.000356	0.00175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.000355	0.00174	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000354	0.00174	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000349	0.00172	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000348	0.00171	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000345	0.0017	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000344	0.00169	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000343	0.00169	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00034	0.00167	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000339	0.00167	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000339	0.00167	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000339	0.00167	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000338	0.00166	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000332	0.00163	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000332	0.00163	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00033	0.00162	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000324	0.0016	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000324	0.0016	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000323	0.00159	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000318	0.00156	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000316	0.00156	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000307	0.00151	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000302	0.00149	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000302	0.00149	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000301	0.00148	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.0003	0.00147	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000299	0.00147	CbGpPWpGaD
Sufentanil—OPRM1—brain—multiple sclerosis	0.000298	0.0356	CbGeAlD
Sufentanil—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000297	0.00146	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000296	0.00146	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000291	0.00143	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000291	0.00143	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.00029	0.00143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000288	0.00142	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000286	0.00141	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000286	0.00141	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000279	0.00137	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000274	0.00135	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000274	0.00135	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00027	0.00133	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000269	0.00133	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000268	0.00132	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000264	0.0013	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000264	0.0013	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000262	0.00129	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000262	0.00129	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.00026	0.00128	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000254	0.00125	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.000253	0.00124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000252	0.00124	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000251	0.00124	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000247	0.00121	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000246	0.00121	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000245	0.00121	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000245	0.00121	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000242	0.00119	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000239	0.00118	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000238	0.00117	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000237	0.00116	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000234	0.00115	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000231	0.00114	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00023	0.00113	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000229	0.00113	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000228	0.00112	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000223	0.0011	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000222	0.00109	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000222	0.00109	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000221	0.00109	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.00022	0.00108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.00022	0.00108	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000218	0.00107	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000218	0.00107	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000218	0.00107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000215	0.00106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000214	0.00105	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000212	0.00104	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000209	0.00103	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000209	0.00103	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000207	0.00102	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000205	0.00101	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000201	0.000987	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0002	0.000984	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.0002	0.000984	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000198	0.000974	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000195	0.000961	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000194	0.000957	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000193	0.000949	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000192	0.000943	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000192	0.000943	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000191	0.000941	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000188	0.000925	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000188	0.000924	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000187	0.000919	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000182	0.000893	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000179	0.000883	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000177	0.000871	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000177	0.000869	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000174	0.000854	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000173	0.000853	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.00017	0.000839	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.00017	0.000834	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000169	0.000832	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000167	0.00082	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000165	0.00081	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000163	0.000802	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000162	0.000797	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000162	0.000797	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000162	0.000795	CbGpPWpGaD
Sufentanil—CYP3A4—nervous system—multiple sclerosis	0.000159	0.019	CbGeAlD
Sufentanil—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.000156	0.000766	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000154	0.000756	CbGpPWpGaD
Sufentanil—CYP3A4—central nervous system—multiple sclerosis	0.000153	0.0183	CbGeAlD
Sufentanil—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000151	0.000745	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.00015	0.000737	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.000149	0.000735	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000148	0.00073	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.000148	0.000726	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000147	0.000722	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000146	0.000719	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.000145	0.000712	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.000143	0.000705	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.000141	0.000693	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000139	0.000684	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	0.000137	0.000672	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	0.000135	0.000663	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000133	0.000653	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.000132	0.00065	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	0.000131	0.000647	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.00013	0.000639	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PGR—multiple sclerosis	0.000129	0.000637	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	0.000127	0.000624	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000126	0.000622	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CD28—multiple sclerosis	0.000126	0.000619	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000125	0.000617	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000124	0.000608	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	0.000123	0.000607	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.00012	0.000591	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.000117	0.000578	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.000117	0.000576	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	0.000116	0.00057	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000115	0.000568	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SRM—multiple sclerosis	0.000115	0.000564	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	0.000114	0.000561	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000114	0.00056	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000112	0.000552	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000111	0.000546	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.000109	0.000538	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000107	0.000528	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000107	0.000525	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000106	0.000523	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	0.000106	0.000523	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	0.000105	0.000518	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000104	0.000513	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	0.000103	0.000507	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	0.000103	0.000505	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.000102	0.000503	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000101	0.000495	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	9.8e-05	0.000482	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	9.77e-05	0.000481	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	9.63e-05	0.000474	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	9.35e-05	0.00046	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	9.33e-05	0.000459	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	9.07e-05	0.000446	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CD86—multiple sclerosis	8.97e-05	0.000441	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	8.94e-05	0.00044	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	8.9e-05	0.000438	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	8.87e-05	0.000437	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	8.83e-05	0.000434	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	8.7e-05	0.000428	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	8.67e-05	0.000427	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	8.57e-05	0.000422	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—multiple sclerosis	8.25e-05	0.000406	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	8.18e-05	0.000402	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.07e-05	0.000397	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.07e-05	0.000397	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	7.96e-05	0.000391	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	7.9e-05	0.000389	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	7.84e-05	0.000386	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	7.78e-05	0.000383	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD86—multiple sclerosis	7.58e-05	0.000373	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	7.46e-05	0.000367	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CD80—multiple sclerosis	7.46e-05	0.000367	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.38e-05	0.000363	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	7.24e-05	0.000356	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—multiple sclerosis	7.24e-05	0.000356	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—POMC—multiple sclerosis	7.09e-05	0.000349	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	6.94e-05	0.000341	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	6.91e-05	0.00034	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	6.79e-05	0.000334	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	6.72e-05	0.000331	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	6.63e-05	0.000326	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	6.58e-05	0.000324	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CD80—multiple sclerosis	6.54e-05	0.000322	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	6.3e-05	0.00031	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—POMC—multiple sclerosis	6.22e-05	0.000306	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.12e-05	0.000301	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—multiple sclerosis	6.12e-05	0.000301	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	6.08e-05	0.000299	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	5.95e-05	0.000293	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CD80—multiple sclerosis	5.53e-05	0.000272	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	5.52e-05	0.000272	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—POMC—multiple sclerosis	5.25e-05	0.000259	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—multiple sclerosis	5.24e-05	0.000258	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	5.22e-05	0.000257	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	5.14e-05	0.000253	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.03e-05	0.000248	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	4.96e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	4.67e-05	0.00023	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—multiple sclerosis	4.6e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	4.57e-05	0.000225	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	4.41e-05	0.000217	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	4.35e-05	0.000214	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—multiple sclerosis	4.1e-05	0.000202	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	4.09e-05	0.000201	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	4.01e-05	0.000197	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—multiple sclerosis	3.88e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	3.87e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	3.87e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	3.68e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—multiple sclerosis	3.59e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	3.59e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	3.52e-05	0.000173	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.51e-05	0.000173	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	3.27e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—multiple sclerosis	3.08e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—multiple sclerosis	3.04e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.03e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	2.97e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—multiple sclerosis	2.7e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—multiple sclerosis	2.28e-05	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—multiple sclerosis	2.11e-05	0.000104	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—POMC—multiple sclerosis	1.82e-05	8.94e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—multiple sclerosis	1.66e-05	8.15e-05	CbGpPWpGaD
